Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)
Japan
· Delayed Price · Currency is JPY
Full Chart
Watchlist
Alerts
Compare
938.00
-10.00 (-1.05%)
Jun 3, 2026, 3:30 PM JST
Overview
Financials
Statistics
Dividends
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Quarterly
TTM
TYO:6039 Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Mil
Millions
Data
Data Source
JPY
JPY
More
Download
Full Width
Fiscal Year
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
Period Ending
Mar '26
Mar 31, 2026
Mar '25
Mar 31, 2025
Mar '24
Mar 31, 2024
Mar '23
Mar 31, 2023
Mar '22
Mar 31, 2022
Revenue
6,192
5,277
4,270
3,872
2,979
Revenue Growth (YoY)
17.34%
23.58%
10.28%
29.98%
4.64%
Cost of Revenue
3,685
3,445
2,806
2,430
1,873
Gross Profit
2,507
1,832
1,464
1,442
1,106
Selling, General & Admin
1,357
999
868
758
576
Other Operating Expenses
-
88
69
68
59
Operating Expenses
1,357
1,111
967
862
666
Operating Income
1,150
721
497
580
440
Interest Expense
-36
-26
-19
-17
-13
Other Non Operating Income (Expenses)
31
25
31
-13
11
EBT Excluding Unusual Items
1,145
720
509
550
438
Gain (Loss) on Sale of Assets
-4
-1
-18
-17
-1
Other Unusual Items
-
-
-
-
-15
Pretax Income
1,141
719
491
533
422
Income Tax Expense
308
199
154
153
136
Net Income
833
520
337
380
286
Net Income to Common
833
520
337
380
286
Net Income Growth
60.19%
54.30%
-11.32%
32.87%
0.35%
Shares Outstanding (Basic)
13
13
14
12
12
Shares Outstanding (Diluted)
13
13
14
12
12
Shares Change (YoY)
-0.34%
-6.73%
11.92%
2.18%
-0.26%
EPS (Basic)
64.45
40.15
24.59
31.21
24.11
EPS (Diluted)
64.45
40.15
24.25
30.64
23.60
EPS Growth
60.54%
65.55%
-20.85%
29.83%
0.87%
Free Cash Flow
-954
418
-141
82
-44
Free Cash Flow Per Share
-73.82
32.23
-10.14
6.60
-3.62
Dividend Per Share
-
7.400
4.000
-
-
Dividend Growth
-
85.00%
-
-
-
Gross Margin
40.49%
34.72%
34.29%
37.24%
37.13%
Operating Margin
18.57%
13.66%
11.64%
14.98%
14.77%
Profit Margin
13.45%
9.85%
7.89%
9.81%
9.60%
Free Cash Flow Margin
-15.41%
7.92%
-3.30%
2.12%
-1.48%
EBITDA
1,738
1,291
961
991
681
EBITDA Margin
28.07%
24.46%
22.51%
25.59%
22.86%
D&A For EBITDA
588
570
464
411
241
EBIT
1,150
721
497
580
440
EBIT Margin
18.57%
13.66%
11.64%
14.98%
14.77%
Effective Tax Rate
26.99%
27.68%
31.36%
28.71%
32.23%